Steven Cohen Dbv Technologies S.A. Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.42 - $2.23 $4.42 Million - $6.94 Million	3,112,500 New	3,112,500 $5.91 Million
Q4 2019 Feb 14, 2020	SELL	$6.75 - $11.15 $2.82 Million - $4.65 Million	-417,064 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$8.57 - $10.72 $2.1 Million - $2.63 Million	245,364 Added 142.9%	417,064 $3.59 Million
Q2 2019 Aug 14, 2019	BUY	$7.58 - $10.0 $1.3 Million - $1.72 Million	171,700 New	171,700 $1.41 Million
Q4 2017 Feb 14, 2018	SELL	$20.9 - $49.36 $1.08 Million - $2.55 Million	-51,600 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$39.62 - $46.17 $2.04 Million - $2.38 Million	51,600	51,600 $2.19 Million

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $599M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.